Business
CORRECTING and REPLACING: Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies launches an approximately €22 million capital increase to support commercialization of eyonis® LCS in the U.S. ...
SOPHIA ANTIPOLIS, France, July 23, 2025--Regulatory News: This press release cancels and supersedes the press release with the same subject published by the Company on July 21, 2025 – 10:00 p.m. CEST.
About this update from Median Technologies
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1240,"height":461,"url":"https://media.zenfs.com/en/business-wire.com/c6d0a8291d06fd21d00632ac8b9881fc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/iR6Y3WcNhkGb5NJyhvPqGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1NztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c6d0a8291d06fd21d00632ac8b9881fc","width":960,"height":357},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/HDarv79D.FLdhwdZT04sLQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/c6d0a8291d06fd21d00632ac8b9881fc","width":1200,"height":446}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Capital increase in the form of shares with attached warrants ("ABSA") without preferential subscription rights by way of an equity public offering and with a priority subscription period of 5 trading days on an irreducible and reducible basis for an estimated amount of €22.0 million","length":294,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Subscription price: €1.66 for one ABSA","length":38,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Subscription period of the priority subscription and the public offering from July 23, 2025 until 5:00 pm CEST on July 29, 2025","length":127,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Minimum orders accepted as part of the capital increase: €100,000 per investor","length":78,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Subscription commitments received of approximately €17.2 million (78 % of the offering)","length":87,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net proceeds of the transaction are intended to support eyonis® Lung Cancer Screening (LCS) Software as a Medical Device’s commercial launch, sales ramp-up in U.S., as well as the expansion of the eyonis® suite of products for image-based early cancer diagnosis","length":261,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":885,"olType":false},{"type":"text","content":"SOPHIA ANTIPOLIS, France, July 23, 2025--(BUSINESS WIRE)--Regulatory News:","length":74,"tagName":"p"},{"type":"text","content":"This press release cancels and supersedes the press ...